Merck, Sanofi join Novartis’ 10-year quest to improve clinical trial diversity as historically Black colleges pitch in

Kyle LaHucik

Senior Reporter

Merck and Sanofi are joining Novartis’ 10-year commitment to increasing diversity in clinical research through a collaboration with historically Black colleges and universities.

With new …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Merck, Sanofi join Novartis’ 10-year quest to improve clinical trial diversity as historically Black colleges pitch in

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Mer­ck, Sanofi join No­var­tis’ 10-year quest to im­prove clin­i­cal tri­al di­ver­si­ty as his­tor­i­cal­ly Black col­leges pitch in

Senior Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Merck, Sanofi join Novartis’ 10-year quest to improve clinical trial diversity as historically Black colleges pitch in